Department of Oral and Maxillofacial Surgery, Affiliated Heping Hospital, Changzhi Medical College, Changzhi Shanxi, China.
School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, Liaoning, China.
Ear Nose Throat J. 2023 Oct;102(10):NP522-NP526. doi: 10.1177/01455613211016717. Epub 2021 Jun 16.
The main aim of this article is to discuss and summarize the research advancements and the treatment methods for sweat gland carcinoma (SGC) based on 2 cases of SGC in our hospital and the related literature.
This article presents 2 patients with SGC who were treated in the China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases from 2007 to 2019. We analyzed the clinical features, therapies, and prognosis of the patients and searched for related literatures.
Two patients underwent extended resection for local lesions with no adjuvant radiotherapy. Neither local recurrence nor distant metastasis was detected during follow-up. Reviewing previous literature, the treatment of SGC includes surgical resection, radiotherapy, and chemotherapy. We have not found an effective treatment. The prognosis of SGC occurred in head and neck is relatively good compared with another primary-site location, primary surgical excision with safe resection margins and neck dissection is recommended.
本文主要讨论并总结了 2 例我院汗腺癌(SGC)病例及相关文献的研究进展和治疗方法。
本文报告了 2007 年至 2019 年在中国医科大学辽宁省口腔疾病重点实验室治疗的 2 例 SGC 患者。我们分析了患者的临床特征、治疗方法和预后,并检索了相关文献。
2 例患者均行局部病变扩大切除术,未行辅助放疗。随访期间未发现局部复发或远处转移。回顾以往文献,SGC 的治疗包括手术切除、放疗和化疗。我们尚未找到有效的治疗方法。与其他原发部位相比,发生在头颈部的 SGC 预后较好,建议行原发灶手术切除,安全切缘及颈清扫术。